Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
Operating Expenses | 19,678 | 10,889 | 10,896 | 10,607 | 9,584 |
Operating Income | -19,678 | -10,889 | -10,896 | -10,607 | -9,584 |
Other Income | 203 | 200 | 201 | 236 | 236 |
Pre-tax Income | -19,475 | -10,689 | -10,695 | -10,371 | -9,348 |
Net Income Continuous | -19,475 | -10,689 | -10,695 | -10,371 | -9,348 |
Net Income | $-19,475 | $-10,689 | $-10,695 | $-10,371 | $-9,348 |
EPS Basic Total Ops | -0.68 | -0.40 | -0.53 | 36.19 | -0.47 |
EPS Basic Continuous Ops | -0.68 | -0.40 | -0.53 | 2.81 | -0.47 |
EPS Diluted Total Ops | -0.68 | -0.40 | -0.53 | 36.19 | -0.47 |
EPS Diluted Continuous Ops | -0.68 | -0.40 | -0.53 | 2.81 | -0.47 |
EBITDA(a) | $-19,496 | $-10,722 | $-10,742 | $-10,447 | $-9,472 |